Patent: 11,311,629
Summary for Patent: 11,311,629
| Title: | DNA-templated micelle and uses thereof |
| Abstract: | The present invention discloses a multifunctional DNA-templated micelle system that has a payload carrier of at least a DNA bridge and a functionalized polyethylene glycol (PEG) segment. The micelle can be used to deliver molecules, such as drugs and polynucleotides, to targeted cells for pharmaceutical uses. The PEG segment provides a functional group, such as amine, for ligand conjugation. The DNA-templated micelle of the present invention is highly controllable in size, loading efficiency and tissue targeting, and can carry multiple payloads for targeted combination strategies in cancer therapy, such as gene delivery, gene therapy, and immunotherapy. |
| Inventor(s): | Kam W. Leong, Yeh-Hsing LAO, Tzu-Chieh HO, Smruthi SURYAPRAKASH |
| Assignee: | Columbia University in the City of New York |
| Application Number: | US16/492,320 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,311,629
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | January 31, 2022 | ⤷ Start Trial | 2038-02-27 |
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | September 11, 2023 | ⤷ Start Trial | 2038-02-27 |
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | July 9, 2025 | ⤷ Start Trial | 2038-02-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,311,629
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2021128746 | ⤷ Start Trial |
| United States of America | 2022313839 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2018164883 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
